Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2058 to 2107 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna damage binding protein 1 (damage-specific dna binding protein 1) (ddb p127 subunit) (ddba) (uv-damaged dna-binding protein 1) (uv-ddb 1) (xeroderma pigmentosum group e complementing protein) (xpce) (x- associated protein 1) (xap-1). [source:swissprot;acc:q16531]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.364\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03168\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1030\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
propionyl-coa carboxylase beta chain, mitochondrial precursor (ec 6.4.1.3) (pccase beta subunit) (propanoyl-coa:carbon dioxide ligase beta subunit). [source:swissprot;acc:p05166]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinol dehydrogenase 8 (all-trans); photoreceptor outer segment all-trans retinol dehydrogenase. [source:refseq;acc:nm\_015725]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.549\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1031\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hcv ns3-transactivated protein 1. [source:refseq;acc:nm\_019048]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.468\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.542\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable ribosome biogenesis protein nep1 (c2f protein). [source:swissprot;acc:q92979]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.978\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.518\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03167\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1032\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
186.664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
180.943\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03162\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase catalytic subunit a, ubiquitous isoform (ec 3.6.3.14) (v-atpase a subunit 1) (vacuolar proton pump alpha subunit 1) (v-atpase 69 kda subunit 1) (isoform va68). [source:swissprot;acc:p38606]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.468\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
6.542\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1033\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (glutamine- dependent asparagine synthetase) (ts11 cell cycle control protein). [source:swissprot;acc:p08243]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03161\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1034\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.974\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.532\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
180.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0316\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1035\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atrophin-1 interacting protein 1; activin receptor interacting protein 1; likely ortholog of mouse activin receptor interacting protein 1; atrophin-1 interacting protein a; membrane associated guanylate kinase 2; activin receptor interacting p. [source:refseq;acc:nm\_012301]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.682\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03157\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.972\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.531\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1036\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
171.341\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
176.746\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03155\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.719\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.236\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.517\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1037\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nemo-like kinase; likely ortholog of mouse nemo like kinase. [source:refseq;acc:nm\_016231]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
218.162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.514\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin-like; pkc-interacting cousin of thioredoxin. [source:refseq;acc:nm\_006541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.412\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.609\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03151\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1038\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
186.741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03148\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
elks protein. [source:refseq;acc:nm\_015064]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.514\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1039\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.719\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.236\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03137\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.118\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.685\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
6.433\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1040\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, epsilon subunit (tcp-1-epsilon) (cct-epsilon). [source:swissprot;acc:p48643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
168.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03136\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1041\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.433\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03134\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1042\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
186.799\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03132\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 2 (wbp-2). [source:swissprot;acc:q969t9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.901\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.485\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.416\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1043\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.834\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
182.137\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03128\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.382\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1044\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
activator of camp-responsive element modulator (crem) in testis; lim protein act. [source:refseq;acc:nm\_020482]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
269.157\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
275.531\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.374\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex associated-testis-expressed 1-like (protein 91/23). [source:swissprot;acc:p51808]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
173.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.889\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03121\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1045\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cystathionine beta-synthase (ec 4.2.1.22) (serine sulfhydrase) (beta-thionase). [source:swissprot;acc:p35520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.366\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
115.817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
119.432\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03121\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1046\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
double-strand break repair protein mre11a (mre11 homolog 1). [source:swissprot;acc:p49959]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
173.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.889\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein rhoc (h9). [source:swissprot;acc:p08134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.366\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1047\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err1 (estrogen-related receptor, alpha) (err-alpha) (estrogen receptor-like 1). [source:swissprot;acc:p11474]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.391\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03104\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thiosulfate sulfurtransferase (ec 2.8.1.1) (rhodanese). [source:swissprot;acc:q16762]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.366\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1048\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
182.308\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.031\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
3-mercaptopyruvate sulfurtransferase (ec 2.8.1.2) (mst). [source:swissprot;acc:p25325]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.366\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1049\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenine phosphoribosyltransferase (ec 2.4.2.7) (aprt). [source:swissprot;acc:p07741]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03097\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein rhoa (h12). [source:swissprot;acc:p06749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.366\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1050\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
239.505\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.32\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 1 (ec 1.1.1.62) (17-beta-hsd 1) (placental 17-beta-hydroxysteroid dehydrogenase) (20 alpha- hydroxysteroid dehydrogenase) (20-alpha-hsd) (e2dh). [source:swissprot;acc:p14061]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.449\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.998\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03097\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1051\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.378\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.295\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1052\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
220.291\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.584\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.293\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinol dehydrogenase 8 (all-trans); photoreceptor outer segment all-trans retinol dehydrogenase. [source:refseq;acc:nm\_015725]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03097\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1053\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.655\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.27\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 5 (ec 3.4.25.1) (proteasome zeta chain) (macropain zeta chain) (multicatalytic endopeptidase complex zeta chain). [source:swissprot;acc:p28066]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03087\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l21. [source:swissprot;acc:p46778]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
223.958\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03082\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/